Clinical Trials

Hodgkin's Lymphoma

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 5 of 5 Clinical Trials Related to Hodgkin's Lymphoma

ANHL12P1 Anaplastic Lymphoma Study (PRO00001704)

A randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749410), or Crizotinib (NSC# 749005, commercially labeled) in Combination with Chemotherapy for Newly Diagnosed Patients with Anaplastic Lymphoma (ALCL) IND#